Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase.
Porter, J., Lumb, S., Lecomte, F., Reuberson, J., Foley, A., Calmiano, M., le Riche, K., Edwards, H., Delgado, J., Franklin, R.J., Gascon-Simorte, J.M., Maloney, A., Meier, C., Batchelor, M.(2009) Bioorg Med Chem Lett 19: 397-400
- PubMed: 19059779 
- DOI: https://doi.org/10.1016/j.bmcl.2008.11.062
- Primary Citation of Related Structures:  
3F66 - PubMed Abstract: 
A series of quinoxaline inhibitors of c-Met kinase is described. The postulated binding mode was confirmed by an X-ray crystal structure and optimisation of the series was performed on the basis of this structure. Future directions for development of the series are discussed together with the identification of a novel quinoline scaffold.
Organizational Affiliation: 
UCB Celltech, 216 Bath Road, Slough SL1 3WE, United Kingdom. john.porter@ucb-group.com